• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二例全球范围内携带RAF1 S259Y新突变且患有新生儿肥厚型心肌病的努南综合征严重临床表型。

A severe clinical phenotype of Noonan syndrome with neonatal hypertrophic cardiomyopathy in the second case worldwide with RAF1 S259Y neomutation.

作者信息

Jaouadi Hager, Chehida Amel Ben, Kraoua Lilia, Etchevers Heather C, Argiro Laurent, Kasdallah Nadia, Blibech Sonia, Delague Valérie, Lévy Nicolas, Tebib Néji, Mrad Ridha, Abdelhak Sonia, Benkhalifa Rym, Zaffran Stéphane

机构信息

Biomedical Genomics and Oncogenetics Laboratory LR16IPT05,Institut Pasteur de Tunis,Université Tunis El Manar,Tunis,Tunisia.

Department of Pediatrics and Metabolic Diseases,La Rabta Hospital,Faculty of Medicine of Tunis,University of Tunis El Manar,Tunis,Tunisia.

出版信息

Genet Res (Camb). 2019 Apr 29;101:e6. doi: 10.1017/S0016672319000041.

DOI:10.1017/S0016672319000041
PMID:31030682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7045029/
Abstract

Noonan syndrome and related disorders are a group of clinically and genetically heterogeneous conditions caused by mutations in genes of the RAS/MAPK pathway. Noonan syndrome causes multiple congenital anomalies, which are frequently accompanied by hypertrophic cardiomyopathy (HCM). We report here a Tunisian patient with a severe phenotype of Noonan syndrome including neonatal HCM, facial dysmorphism, severe failure to thrive, cutaneous abnormalities, pectus excavatum and severe stunted growth, who died in her eighth month of life. Using whole exome sequencing, we identified a de novo mutation in exon 7 of the RAF1 gene: c.776C > A (p.Ser259Tyr). This mutation affects a highly conserved serine residue, a main mediator of Raf-1 inhibition via phosphorylation. To our knowledge the c.776C > A mutation has been previously reported in only one case with prenatally diagnosed Noonan syndrome. Our study further supports the striking correlation of RAF1 mutations with HCM and highlights the clinical severity of Noonan syndrome associated with a RAF1 p.Ser259Tyr mutation.

摘要

努南综合征及相关疾病是一组临床和遗传异质性疾病,由RAS/MAPK信号通路基因的突变引起。努南综合征会导致多种先天性异常,常伴有肥厚型心肌病(HCM)。我们在此报告一名突尼斯患者,其患有努南综合征的严重表型,包括新生儿肥厚型心肌病、面部畸形、严重发育不良、皮肤异常、漏斗胸和严重生长发育迟缓,该患者在其生命的第八个月死亡。通过全外显子组测序,我们在RAF1基因的第7外显子中鉴定出一个新发突变:c.776C>A(p.Ser259Tyr)。该突变影响一个高度保守的丝氨酸残基,这是通过磷酸化抑制Raf-1的主要介质。据我们所知,c.776C>A突变此前仅在一例产前诊断为努南综合征的病例中被报道过。我们的研究进一步支持了RAF1突变与肥厚型心肌病之间的显著相关性,并突出了与RAF1 p.Ser259Tyr突变相关的努南综合征的临床严重性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe0/7045029/cbcb13df062f/S0016672319000041_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe0/7045029/d2ee8f8bd139/S0016672319000041_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe0/7045029/2998062fb36d/S0016672319000041_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe0/7045029/cbcb13df062f/S0016672319000041_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe0/7045029/d2ee8f8bd139/S0016672319000041_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe0/7045029/2998062fb36d/S0016672319000041_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe0/7045029/cbcb13df062f/S0016672319000041_fig3.jpg

相似文献

1
A severe clinical phenotype of Noonan syndrome with neonatal hypertrophic cardiomyopathy in the second case worldwide with RAF1 S259Y neomutation.第二例全球范围内携带RAF1 S259Y新突变且患有新生儿肥厚型心肌病的努南综合征严重临床表型。
Genet Res (Camb). 2019 Apr 29;101:e6. doi: 10.1017/S0016672319000041.
2
The novel RAF1 mutation p.(Gly361Ala) located outside the kinase domain of the CR3 region in two patients with Noonan syndrome, including one with a rare brain tumor.在两名努南综合征患者中发现了位于CR3区域激酶结构域外的新型RAF1突变p.(Gly361Ala),其中一名患者患有罕见的脑瘤。
Am J Med Genet A. 2018 Feb;176(2):470-476. doi: 10.1002/ajmg.a.38569. Epub 2017 Dec 22.
3
Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.诱导多能干细胞衍生的心肌细胞揭示异常细胞外调节激酶 5 和丝裂原活化蛋白激酶激酶 1/2 信号同时促进 RAF1 相关诺南综合征中的肥厚型心肌病。
Circulation. 2019 Jul 16;140(3):207-224. doi: 10.1161/CIRCULATIONAHA.118.037227. Epub 2019 Jun 5.
4
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.功能获得性RAF1突变导致伴有肥厚型心肌病的努南综合征和豹皮综合征。
Nat Genet. 2007 Aug;39(8):1007-12. doi: 10.1038/ng2073. Epub 2007 Jul 1.
5
Neonatal pulmonary arterial hypertension and Noonan syndrome: two fatal cases with a specific RAF1 mutation.新生儿肺动脉高压与努南综合征:两例携带特定RAF1突变的致命病例。
Am J Med Genet A. 2015 Apr;167A(4):882-5. doi: 10.1002/ajmg.a.37024. Epub 2015 Feb 23.
6
Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders.靶向/外显子组测序在10名被诊断患有努南综合征及相关疾病的中国患者中发现了突变。
BMC Med Genomics. 2017 Oct 30;10(1):62. doi: 10.1186/s12920-017-0298-6.
7
Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.NRAS 信号通路相关疾病 RAF1 基因突变的分子和临床分析:丝氨酸 259 去磷酸化是 RAF1 突变激活的关键机制。
Hum Mutat. 2010 Mar;31(3):284-94. doi: 10.1002/humu.21187.
8
MEK Inhibition in a Newborn with -Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease.MEK 抑制治疗伴 PTPN11 突变的新生儿神经纤维瘤病样综合征相关肺动脉高压和肥厚型心肌病
Genes (Basel). 2021 Dec 21;13(1):6. doi: 10.3390/genes13010006.
9
MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.MEK-ERK 通路调节改善了伴有 Raf1(L613V)突变的诺南综合征小鼠模型的疾病表型。
J Clin Invest. 2011 Mar;121(3):1009-25. doi: 10.1172/JCI44929. Epub 2011 Feb 21.
10
Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.LZTR1 突变阳性的努南综合征患者的鉴定及 LZTR1 与 RAF1-PPP1CB 复合物结合的鉴定。
Hum Genet. 2019 Jan;138(1):21-35. doi: 10.1007/s00439-018-1951-7. Epub 2018 Oct 27.

引用本文的文献

1
Noonan Syndrome and Heart Failure in a Postpartum Patient.产后患者的努南综合征与心力衰竭
Cureus. 2025 Apr 11;17(4):e82109. doi: 10.7759/cureus.82109. eCollection 2025 Apr.
2
RAF-1 Mutation Associated with a Risk for Ventricular Arrhythmias in a Child with Noonan Syndrome and Cardiovascular Pathology.与努南综合征和心血管病变患儿室性心律失常风险相关的RAF-1突变
J Crit Care Med (Targu Mures). 2022 May 12;8(2):126-130. doi: 10.2478/jccm-2022-0007. eCollection 2022 Apr.
3
MEK Inhibition in a Newborn with -Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease.

本文引用的文献

1
VarAFT: a variant annotation and filtration system for human next generation sequencing data.VarAFT:一种用于人类下一代测序数据的变异注释和过滤系统。
Nucleic Acids Res. 2018 Jul 2;46(W1):W545-W553. doi: 10.1093/nar/gky471.
2
Clinical Presentation and Natural History of Hypertrophic Cardiomyopathy in RASopathies.RASopathies相关肥厚型心肌病的临床表现与自然病史
Heart Fail Clin. 2018 Apr;14(2):225-235. doi: 10.1016/j.hfc.2017.12.005.
3
RAF1 variants causing biventricular hypertrophic cardiomyopathy in two preterm infants: further phenotypic delineation and review of literature.
MEK 抑制治疗伴 PTPN11 突变的新生儿神经纤维瘤病样综合征相关肺动脉高压和肥厚型心肌病
Genes (Basel). 2021 Dec 21;13(1):6. doi: 10.3390/genes13010006.
导致两名早产儿双心室肥厚型心肌病的RAF1变异体:进一步的表型描述及文献综述
Clin Dysmorphol. 2017 Oct;26(4):195-199. doi: 10.1097/MCD.0000000000000194.
4
Retrospective study of prenatal ultrasound findings in newborns with a Noonan spectrum disorder.对患有努南综合征谱系障碍新生儿的产前超声检查结果的回顾性研究。
Prenat Diagn. 2016 May;36(5):418-23. doi: 10.1002/pd.4797. Epub 2016 Mar 28.
5
Cardiomyopathies in Noonan syndrome and the other RASopathies.努南综合征及其他RAS病中的心肌病
Prog Pediatr Cardiol. 2015 Jul 1;39(1):13-19. doi: 10.1016/j.ppedcard.2015.01.002.
6
Neonatal pulmonary arterial hypertension and Noonan syndrome: two fatal cases with a specific RAF1 mutation.新生儿肺动脉高压与努南综合征:两例携带特定RAF1突变的致命病例。
Am J Med Genet A. 2015 Apr;167A(4):882-5. doi: 10.1002/ajmg.a.37024. Epub 2015 Feb 23.
7
Identification of a novel de novo deletion in RAF1 associated with biventricular hypertrophy in Noonan syndrome.在努南综合征中鉴定出一种与双心室肥厚相关的RAF1基因新的从头缺失。
Am J Med Genet A. 2014 Aug;164A(8):2069-73. doi: 10.1002/ajmg.a.36588. Epub 2014 Apr 29.
8
Cardiovascular disease in Noonan syndrome.努南综合征相关心血管疾病
Arch Dis Child. 2014 Jul;99(7):629-34. doi: 10.1136/archdischild-2013-305047. Epub 2014 Feb 17.
9
Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry.努南综合征合并肥厚型心肌病患儿的结局:来自儿科心肌病登记处的研究。
Am Heart J. 2012 Sep;164(3):442-8. doi: 10.1016/j.ahj.2012.04.018. Epub 2012 Aug 9.
10
Signaling to cardiac hypertrophy: insights from human and mouse RASopathies.信号转导与心肌肥厚:来自人类和小鼠 RAS opathy 的新视角。
Mol Med. 2012 Sep 7;18(1):938-47. doi: 10.2119/molmed.2011.00512.